Adial Pharmaceuticals (ADIL) Other Non Operating Income (2018 - 2025)
Adial Pharmaceuticals (ADIL) posted Other Non Operating Income of $164862.0 for Q3 2025, up 19247.74% sequentially from -$861.0 in Q2 2025, and up 383500.0% YoY from N/an in Q3 2024.
Adial Pharmaceuticals (ADIL) Other Non Operating Income (2018 - 2025) Analysis & Trends
Adial Pharmaceuticals has reported Other Non Operating Income for 7 years, with the latest figure at $164862.0 in Q3 2025.
- Quarterly Other Non Operating Income rose 383500.0% year-over-year to $164862.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $330194.0 (up 432.77% YoY) and the FY2025 annual result came in at $164854.0, up 319.68% from the prior year.
- Other Non Operating Income climbed to $164862.0 in Q3 2025 per ADIL's latest filing, from -$861.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $325000.0 in Q4 2022 and troughed at -$274524.0 in Q3 2021.
- A 5-year average of $38656.3 and a median of $3137.0 in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 395900.0% in 2025, down 86000.0% in 2025.
- Over 5 years, Other Non Operating Income stood at $54014.0 in 2021, then soared by 501.7% to $325000.0 in 2022, then sank by 80.9% to $62063.0 in 2023, then sank by 100.07% to -$43.0 in 2024, then surged by 383500.0% to $164862.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $164862.0, -$861.0, and $166236.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 164,862.00 |
| Jun 30, 2025 | -861.00 |
| Mar 31, 2025 | 166,236.00 |
| Sep 30, 2024 | -43.00 |
| Jun 30, 2024 | -1.00 |
| Mar 31, 2024 | -42.00 |
| Dec 31, 2023 | 62,063.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 75,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | 146,000.00 |
| Dec 31, 2021 | 54,014.00 |
| Sep 30, 2021 | -274,524.00 |
| Jun 30, 2021 | -67,478.00 |
| Mar 31, 2021 | 6,275.00 |
| Jun 30, 2020 | 2,500.00 |
| Sep 30, 2018 | -3.50 Mn |
| Mar 31, 2018 | 12,241.00 |